Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis

被引:25
|
作者
Wu, Xinle [1 ]
Li, Yang [1 ]
机构
[1] Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA
来源
AGING-US | 2009年 / 1卷 / 12期
关键词
fibroblast growth factors; FGF19; FGF21; FGF23; aging; diabetes; metabolic diseases; insulin; METABOLIC-ACTIVITY; BETA-KLOTHO; GROWTH; SPECIFICITY; SUPPRESSION; DETERMINES; EXPRESSION; SIGNAL; FAMILY; MODE;
D O I
10.18632/aging.100108
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FGF19, FGF21, and FGF23 form a unique subfamily of fibroblast growth factors. Because they contain intra molecular disulfide bonds and show reduced affinity toward heparan sulfate located in the extracellular space, it is thought that, in contrast to other FGFs, they function as endocrine hormones. FGF23 and its co-receptor alpha Klotho are involved in the control of aging, but it is not known if the same holds true for FGF19, which can also signal through alpha Klotho. However, considerable evidence supports a role for FGF19 in controlling various aspects of metabolism. We have recently fully characterized FGF19/FGFR/co-factor interactions and signaling, and in the current manuscript discuss the contribution of the FGF19/FGFR4 axis to bile acid and glucose regulation.
引用
收藏
页码:1023 / 1027
页数:5
相关论文
共 50 条
  • [31] Ponatinib and gossypol act in synergy to suppress colorectal cancer cells by modulating apoptosis/autophagy crosstalk and inhibiting the FGF19/FGFR4 axis
    Naglaa M.El-Lakkany
    Hadeel H.Elkattan
    Alaa E.Elsisi
    Asian Pacific Journal of Tropical Biomedicine, 2023, (03) : 131 - 138
  • [32] THE ROLE OF FGFR4 IN NEUROBLASTOMA
    Whittle, Sarah
    Du, Melissa
    Zhang, Linna
    Woodfield, Sarah
    Scheurer, Michael
    Okcu, Fatih
    Zage, Peter
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S97 - S98
  • [33] FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis
    Tianli Chen
    Hongda Liu
    Zengli Liu
    Kangshuai Li
    Ruixi Qin
    Yue Wang
    Jialiang Liu
    Zhipeng Li
    Qinglun Gao
    Chang Pan
    Fan Yang
    Wei Zhao
    Zongli Zhang
    Yunfei Xu
    Oncogene, 2021, 40 : 4941 - 4953
  • [34] FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis
    Chen, Tianli
    Liu, Hongda
    Liu, Zengli
    Li, Kangshuai
    Qin, Ruixi
    Wang, Yue
    Liu, Jialiang
    Li, Zhipeng
    Gao, Qinglun
    Pan, Chang
    Yang, Fan
    Zhao, Wei
    Zhang, Zongli
    Xu, Yunfei
    ONCOGENE, 2021, 40 (30) : 4941 - 4953
  • [35] Ponatinib and gossypol act in synergy to suppress colorectal cancer cells by modulating apoptosis/autophagy crosstalk and inhibiting the FGF19/FGFR4 axis
    El-Lakkany, Naglaa M.
    Elkattan, Hadeel H.
    Elsisi, Alaa E.
    ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2023, 13 (03) : 131 - 138
  • [36] FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4
    Xie, MH
    Holcomb, I
    Deuel, B
    Dowd, P
    Huang, A
    Vagts, A
    Foster, J
    Liang, J
    Brush, J
    Gu, QM
    Hillan, K
    Goddard, A
    Gurney, AL
    CYTOKINE, 1999, 11 (10) : 729 - 735
  • [37] FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways
    Wu, Ai-Luen
    Coulter, Sally
    Liddle, Christopher
    Wong, Anne
    Eastham-Anderson, Jeffrey
    French, Dorothy M.
    Peterson, Andrew S.
    Sonoda, Junichiro
    PLOS ONE, 2011, 6 (03):
  • [38] Correction: FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis
    Tianli Chen
    Hongda Liu
    Zengli Liu
    Kangshuai Li
    Ruixi Qin
    Yue Wang
    Jialiang Liu
    Zhipeng Li
    Qinglun Gao
    Chang Pan
    Fan Yang
    Wei Zhao
    Zongli Zhang
    Yunfei Xu
    Oncogene, 2023, 42 : 3219 - 3219
  • [39] FGF19 induced hepatocarcinogenesis in mice
    Tao, Junyan
    Singh, Sucha
    Chen, Xin
    Monga, Paul
    FASEB JOURNAL, 2017, 31
  • [40] FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis
    DePaoli, Alex M.
    Zhou, Mei
    Kaplan, Daniel D.
    Hunt, Steven C.
    Adams, Ted D.
    Learned, R. Marc
    Tian, Hui
    Ling, Lei
    DIABETES, 2019, 68 (06) : 1315 - 1328